Rohan Khera reports PROVAR plus tested AI ECG to prioritize limited echocardiography capacity for structural heart disease screening, aiming to make referral queues more efficient when imaging slots are scarce.
When echocardiography capacity is limited, who should get one first?
We tested AI-ECG for triaging echo referrals for structural heart disease in PROVAR+, a large cardiovascular screening program in Brazil
Led & presented by @af_pedroso at #ACC26 and #SimPub in @AJPCardio
We tested AI-ECG for triaging echo referrals for structural heart disease in PROVAR+
a large cardiovascular screening program in Brazil
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare